Led training on pharmacoepidemiology

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201650024A
Awardee
Awarding agency
Obligated
$1,054,686

Award facts

Opportunity
  • 16223SOL00010 Solicitation number
Contract value 100% obligated
$1,054,685.59 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00010 -$96,861
Other Administrative Action P00009 · The purpose of this modification is to incorporate far 52.223-99, ensuring adequate covid-19 safety protocols for federal contractors (OCT 2021) (deviation),… $0
Supplemental Agreement for work within scope P00008 $71,607
Exercise an Option P00007 $200,790
Other Administrative Action P00006 $0
Exercise an Option P00005 $194,929
Other Administrative Action 4 $0
Exercise an Option 3 $185,479
Exercise an Option 2 · Instructor-led training on pharmacoepidemiology $183,683
Other Administrative Action 1 $0
Original award $315,059
Show all 11

About this award

This federal contract award, valued at $1,054,685.59, was granted by the Food and Drug Administration (FDA) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for LED training on pharmacoepidemiology, which involves the study of the use and effects of drugs in large populations. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a renowned private research institution. The University of Pennsylvania has a long history of conducting cutting-edge research and providing services to federal agencies through contracts and grants, including work for the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. This specific contract is part of a larger indefinite delivery contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Pennsylvania to develop and use animal and animal replacement models for evaluating candidate countermeasures against infectious diseases. The $146.3 million IDC has a 7-year ordering period and covers various preclinical research services to support NIAID's infectious disease research programs.

Quick answers

Who was awarded contract HHSF223201650024A?

HHSF223201650024A was awarded to The Trustees Of The University Of Pennsylvania by Food and Drug Administration (Department of Health and Human Services) on September 16, 2016.

How much is contract HHSF223201650024A worth?

The government has obligated $1,054,686 on HHSF223201650024A.

Was contract HHSF223201650024A competed?

The extent of competition for HHSF223201650024A was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award